Abigail Bowring

Abigail Bowring

Auto-generated profile, based on publicly available information

Abigail Bowring

Department of Neuroscience and Experimental Therapeutics, Texas A&M College of Medicine, 8447 John Sharp Parkway, Bryan, TX 77807, United States

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Alcohol Research: Current Reviews
Verified
Journal Article
Closed access
DUDeepa Upreti
Deepa Upreti
RKRosaline P. Kumar
Rosaline P. Kumar
JCJustin Bo-Jiun Chen
Justin Bo-Jiun Chen
SSSneha L. Sonti
Sneha L. Sonti
ABAbigail V. Bowring
Abigail V. Bowring
RMRajesh Miranda
Rajesh Miranda
Key TakeawaysNoncoding RNAs (ncRNAs) dominate the genomes of mammals, including humans, and epigenetically transduce the effects of the environment into all cells and tissues.Understanding of the role of ncRNAs in the pathogenesis of alcohol use disorder (AUD) is in its infancy.Most of the research has focused on very few classes of ncRNAs, mainly on microRNAs.Research has mainly focused on documenting ncRNAs that are altered in various AUD states.

2 July 2025 in Drug and Alcohol Dependence Reports
Verified
Journal Article
Open access
SRSiara K. Rouzer
Siara K. Rouzer
MDMcKay Domen
McKay Domen
AGAisley George
Aisley George
ABAbigail Bowring
Abigail Bowring
RMRajesh Miranda
Rajesh Miranda
This study investigated the effects of prenatal co-exposure to alcohol and synthetic cannabinoids on offspring viability, physical development, and neurobehavioral outcomes in young adulthood. The goal of this investigation was to determine whether prenatal co-exposure produced distinct outcomes from single-drug exposures, including sex-specific vulnerabilities in motor coordination and exploratory behaviors. Pregnant C57Bl/6 J mice were randomly assigned to one of four treatment groups: drug-free controls, alcohol (ALC)-exposed, cannabinoid (CP-55,940, CB)-exposed or ALC+CB-exposed, with drug exposure occurring between Gestational Days 12–15. Offspring viability, physical malformations, and developmental delays were first assessed at birth. Then, behavioral evaluations, including rotarod and open field tests, were conducted on young adult offspring (Postnatal Days 100–120). ALC+CB exposure significantly decreased litter survival (p = 0.006) and offspring viability compared to controls. Non-viable offspring exhibited craniofacial abnormalities, limb malformations, and developmental delays. Assessments of rotarod performance revealed that all exposures reduced motor coordination in males compared to controls (p < 0.05), while ALC and CB exposures alone produced this outcome in females. Open field tests indicated that ALC+CB exposure reduced time in the center of the arena in male offspring exclusively, while this same exposure increased hyperactivity compared to single-drug and control groups, independent of sex (p < 0.05). Prenatal co-exposure to alcohol and synthetic cannabinoids exacerbated offspring mortality and induced sex-specific deficits in neurobehavioral motor outcomes. These findings highlight the distinct risks of polysubstance exposure during pregnancy and underscore the need for targeted interventions to mitigate the effects of prenatal polysubstance exposure on offspring health outcomes.

28 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
SRSiara K. Rouzer
Siara K. Rouzer
MDMcKay Domen
McKay Domen
AGAisley George
Aisley George
ABAbigail Bowring
Abigail Bowring
RMRajesh Miranda
Rajesh Miranda
This study explores the effects of prenatal co-exposure to alcohol and synthetic cannabinoids on offspring viability, physical development, and neurobehavioral outcomes in young adulthood. The aim is to identify distinct outcomes of co-exposure compared to single-drug exposures and to examine potential sex-specific vulnerabilities in motor coordination and exploratory behaviors. Pregnant C57Bl/6J mice were assigned to one of four treatment groups: Control, Alcohol-exposed, Cannabinoid-exposed, or Alcohol+Cannabinoid-exposed, with drug administration occurring between Gestational Days 12–15. Offspring were first evaluated at birth for survival, physical malformations, and developmental delays. Subsequently, young adult offspring were assessed for motor coordination using rotarod tests and exploratory behavior using open field tests. Our results indicate that alcohol and cannabinoid co-exposure significantly reduced offspring survival and litter sizes compared to controls. Non-viable offspring displayed craniofacial abnormalities, limb malformations, and developmental delays. Behavioral assessments in young adulthood demonstrated that all forms of prenatal drug exposure impaired motor coordination in males, while alcohol and cannabinoid exposures independently produced impairments in females. In the open field test, co-exposed male offspring exhibited reduced center exploration, indicative of anxiety-like behavior. Co-exposed offspring, regardless of sex, demonstrated hyperactivity, characterized by increased speed and distance traveled. Together, these findings underscore the heightened risks associated with prenatal polysubstance exposure, which exacerbates offspring mortality and induces sex-specific neurobehavioral deficits. This study highlights the distinct outcomes associated with prenatal co-exposure, and the need for future research to investigate underlying mechanisms driving these developmental disruptions and sex-specific susceptibilities. Structured Purpose: This study investigates the effects of prenatal co-exposure to alcohol and synthetic cannabinoids on offspring viability, physical development, and neurobehavioral outcomes in young adulthood. The goal of this investigation is to determine whether prenatal co-exposure produces distinct outcomes from single-drug exposures, including sex-specific vulnerabilities in motor coordination and exploratory behaviors. Methods: Pregnant C57Bl/6J mice were randomly assigned to one of four treatment groups: drug-free controls, alcohol (ALC)-exposed, cannabinoid (CP-55,940, CB)-exposed or ALC+CB-exposed, with drug exposure occurring between Gestational Days 12-15. Offspring viability, physical malformations, and developmental delays were first assessed at birth. Then, behavioral evaluations, including rotarod and open field tests, were conducted on young adult offspring (Postnatal Days 100–120). Results: ALC+CB exposure significantly decreased litter survival ( p = 0.006) and offspring viability compared to controls. Non-viable offspring exhibited craniofacial abnormalities, limb malformations, and developmental delays. Assessments of rotarod performance revealed that all exposures reduced motor coordination in males compared to controls ( p < 0.05), while ALC and CB exposures alone produced this outcome in females. Open field tests indicated that ALC+CB exposure reduced time in the center of the arena in male offspring exclusively, while this same exposure increased hyperactivity compared to single-drug and control groups, independent of sex ( p < 0.05). Conclusions: Prenatal co-exposure to alcohol and synthetic cannabinoids exacerbates offspring mortality and induces sex-specific deficits in neurobehavioral motor outcomes. These findings highlight the distinct risks of polysubstance exposure during pregnancy and underscore the need for targeted interventions to mitigate the effects of prenatal polysubstance exposure on offspring health outcomes. Highlights: Alcohol and cannabinoid co-exposure significantly reduces offspring survival. Reduced survival is associated with offspring craniofacial and limb malformations. Prenatal exposures produce sex-specific impairments in motor coordination. Co-exposed offspring display hyperactivity in young adulthood.